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http://dxObjective: This study presents a review of our experience with minimally invasive mitral valve surgery
(MIMVS) in patients with a previous cardiac procedure performed through a sternotomy over a 10-year period.
Methods: From November 2003 to August 2013, 173 patients (age 61.3  12.4 years) underwent reoperative
MIMVS through a right minithoracotomy. Previous operations were coronary artery bypass grafting (n ¼ 49;
28.6%), a mitral valve procedure (n ¼ 120; 70.1%), an aortic valve procedure (n ¼ 32; 18.7%), and other op-
erations (n ¼ 14; 8.1%). The mean euroSCORE was 11.2  3.8. The time to redo surgery was 6.9  4.2 years.
Results: Procedures were performed with central aortic cannulation in 55 patients (31.7%) and peripheral
cannulation in 118 (68.3%). A transthoracic clamp was used in 58 patients (33.5%), an endoaortic balloon
in 72 (41.6%), hypothermic ventricular fibrillation in 23 (13.2%), and beating heart in 20 (11.5%). Mean car-
diopulmonary bypass and crossclamp times were 160  58 minutes and 82  49 minutes, respectively. Mitral
repair was performed in 53 patients (30.6%). Forty-three patients (24.7%) had an additional cardiac procedure.
Conversion to sternotomywas necessary in 2 patients (1.1%) and reoperation for bleeding in 11 patients (6.3%).
Thirty-day mortality was 4.1% (n¼ 7). Major morbidities included stroke (n¼ 11; 6%) and new-onset dialysis
requirement (n ¼ 4; 2.3%). The mean blood transfusion requirement was 1.4  1.1 units. Mean follow-up
was 3.3  2.6 years. Survival at 1, 5, and 10 years was 93.1%  1.9%, 87.5%  2.7%, and 79.7% 
3.8%, respectively.
Conclusions: Reoperative mitral valve surgery can be safely performed through a right minithoracotomy with
good early and late outcomes. The avoidance of extensive surgical dissection, optimal valve exposure, and low
blood transfusion are the main advantages of this technique. (J Thorac Cardiovasc Surg 2014;148:2763-8)A
C
DIn recent years, less invasive procedures have emerged as
the new trend in mitral valve surgery. Since the first report
by Carpentier and colleagues,1 the conviction that mini-
mally invasive mitral valve surgery (MIMVS) could be per-
formed with similar hospital mortality to the standard
approach, but with less blood transfusion, earlier recovery
of daily activities, and higher patient satisfaction, have
driven its diffusion in most centers worldwide. Although a
large volume of literature on primary MIMVS is available,
only a few studies have been reported on the use of this tech-
nique in patients who have undergone a previous cardiac
surgical procedure.2 In 2003, we started an MIMVS pro-
gram and from the beginning, video-assisted right thoracot-
omy approach has been the approach of choice for
reoperative mitral valve surgery. The aim of the presente Fondazione Toscana Gabriele Monasterio, G. Pasquinucci Heart Hospital,
a, Italy.
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The Journal of Thoracic and Carstudy is therefore to review our experience with MIMVS
in patients with a previous cardiac operation performed
through a median sternotomy and to assess the effectiveness
and the safety of this approach.
PATIENTS AND METHODS
Patient Selection and Data Collection
This was a retrospective, observational, cohort study of prospectively
collected data from consecutive patients who underwent reoperative
MIMVS via a right minithoracotomy at the G. Pasquinucci Heart Hospital
between November 2003 and August 2013. The data collection form is
entered in an institutional database and includes 5 sections that are filled
in consecutively by anesthetists, surgeons, and nurses in the intensive
care unit, high-dependency unit, and wards. The resulting base sample con-
tained detailed clinical information on 173 patients. No patients were
excluded. The study was approved by the clinical audit committee of the
G. Pasquinucci Heart Hospital to meet ethical and legal requirements,
and individual consent was waived.
Follow-up was conducted from September to October 2013 by tele-
phone interview using a structured questionnaire and was 100% complete.
At our institution, right minithoracotomy is considered the preferred
approach in patients with a previous sternotomy, who require a redo mitral
valve operation alone or with other cardiac procedures such as tricuspid
valve surgery, atrial fibrillation ablation, and closure of an atrial septal
defect. Contraindications for this approach are: previous right pleural dis-
ease, previous right thoracotomy, and the need for a concomitant procedure
such as coronary artery bypass grafting, aortic valve replacement,
ascending aorta replacement, or left ventricular reshaping.diovascular Surgery c Volume 148, Number 6 2763
Abbreviations and Acronyms
CI ¼ confidence interval
HR ¼ hazard ratio
MIMVS ¼ minimally invasive mitral valve surgery
OR ¼ odds ratio
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Hospital mortality included all deaths within 30 days of operation irre-
spective of where the death occurred and all deaths in hospital after 30 days
among patients who had not been discharged after the index operation. Our
definition of perioperative stroke included any new temporary or perma-
nent, focal or global neurologic deficit. Perioperative stroke was diagnosed
during clinical assessment by physicians involved in the daily care of pa-
tients, and was confirmed by computed tomography or magnetic resonance
imaging whenever possible. The diagnosis of stroke was also confirmed
and documented by staff neurologists. Renal complications included acute
renal failure, defined as the requirement for hemodialysis or an increased
creatinine level (>200 mmol/L). A diagnosis of postoperative myocardial
infarction was based on the presence of new Q waves greater than
0.04 milliseconds and/or a reduction in R waves greater than 25% in at
least 2 contiguous leads on an electrocardiogram. Pulmonary complica-
tions included chest infection, ventilation failure, reintubation, and
tracheostomy.Surgical Technique
Our operative technique has been described previously.3 In brief, it con-
sists of a small (5-7 cm) right anterolateral thoracotomy in the third or
fourth intercostal space. After incision, a soft tissue retractor is inserted
and the intercostal space is gently spread with a retractor without rib cut-
ting. Two trocars are inserted in the thorax to allow positioning of a ventric-
ular vent, CO2 insufflator, and a camera device. Based on our belief that
antegrade perfusion has advantages over retrograde flow,4,5 we adopt
central cannulation whenever possible. Under direct visualization, the
aorta is exposed up to the origin of the innominate artery after which 2
concentric purse string sutures for direct arterial cannulation are placed
in a standard fashion into the ascending aorta. The cannulation site is
generally chosen by identifying the transverse sinus as the orientation
where the aortic crossclamp will be placed. It is sufficient if the
cannulation site stays at some distance above the crossclamp level.
Direct ascending aorta cannulation is performed under direct vision. The
lungs must be deflated before aortic cannulation. The adventitia is
prepared with scissors and the aortic cannula is advanced into the aorta.6
Femoral artery cannulation is used in those patients who have an obvious
contraindication to ascending aorta cannulation such as patent saphenous
vein grafts, previous ascending aorta replacement, and/or severe adhesions
around the ascending aorta. Venous drainage is achieved by a long venous
cannula introduced percutaneously into the femoral vein and positioned un-
der transesophageal echo guidance in the right atrium with the tip in the su-
perior vena cava. In the first 5 patients requiring an additional procedure in
the right atrium, an adjunctive right internal jugular vein cannula was in-
serted preoperatively by the anesthetist. However, in the last 28 patients
who required opening of the right atrium, we used a single 2-stage femoral
venous cannula (RAP Venous Cannula, Estech Inc, San Ramon, Calif),
which allows the superior and inferior venae cavae to drain simulta-
neously.6 To achieve good myocardial protection, if the aorta can be safely
dissected and clamped, we prefer to clamp the ascending aorta directly with
a flexible transthoracic clamp and to deliver antegrade cold crystalloid car-
dioplegia. Endoaortic balloon clamping with antegrade cardioplegia is
used in patients in whom the ascending aorta cannot be safely mobilized.
Hypothermic ventricular fibrillation (28C-30C core temperature) or2764 The Journal of Thoracic and Cardiovascular Surbeating heart surgery is used in patients with patent coronary artery bypass
grafts or severe ascending aortic calcifications.
The mitral valve is exposed through a standard left paraseptal atriotomy
with the aid of an atrial retractor supported by an external mechanical arm
inserted in the thorax through a right parasternal hole. Mitral repair is per-
formed using the standard Carpentier techniquewith a combination of thor-
acoscopic assistance and direct vision. Surgical ablation of the atrial
fibrillation is performed with standard endocardial left atrial lesions using
a monopolar radiofrequency probe concomitant with left atrial appendage
exclusion.
Deairing the heart is achieved using a 2-stage procedure. First, the table
is lifted head up, the heart is filled, both lungs are ventilated, and air is
removed from the left atrium with a small forceps inserted through the su-
ture line. The bed is then lifted head down, the aortic clamp is released, and
air is removed via the transmitral vent and the aortic vent. Our favored
operative setup is shown in Figure 1.
Statistical Analyses
Categorical variables are expressed as proportions and continuous var-
iables as means  standard deviation. Stepwise multivariable regression
analysis was used to identify independent risk factors for 30-day mortal-
ity, with a significance level of .05 used for both entry and selection.
Similarly, multivariable Cox proportional hazard modeling was used to
identify independent risk factors for all-cause mortality. Covariates under
consideration for all models were all baseline characteristics (as listed in
Table 1). Overall survival was estimated using the Kaplan-Meier method
and was expressed as a percentage. All reported P values are 2-sided. Sta-
tistical analysis was performed with SPSS version 19.0 (SPSS, Inc,
Chicago, Ill).RESULTS
Patient Characteristics and Operative Data
Preoperative characteristics of the patients are given in
Table 1 and their previous cardiac operations in Table 2.
Mean time to redo surgery was 6.9  4.2 years. This
was the third intervention in 22 patients, the fourth in 4
patients, and the seventh in 1. Mean preoperative euro-
SCORE (European System for Cardiac Operative Risk
Evaluation) was 11.2  3.8. The operation was performed
with direct ascending aorta cannulation in 55 patients
(31.7%) and femoral artery cannulation in 118 (68.3%).
Myocardial protection was achieved with aortic clamping
(transthoracic crossclamp in 58 patients and endoaortic
balloon occluder in 72) and cold crystalloid cardioplegia.
The remaining patients underwent surgery during hypo-
thermic ventricular fibrillation (n ¼ 23; 13.2%) or beating
heart (n ¼ 20; 11.5%). The distribution of valvular proce-
dures performed and concomitant operative procedures is
presented in Table 3. Mean cardiopulmonary bypass and
aortic crossclamp times were 160  48 minutes and 82
 49 minutes, respectively. Conversion to sternotomy
was required in 2 patients during the procedure: due to
atrioventricular disruption in 1 patient and extensive adhe-
sions on the chest wall in the other. A mitral repair was
performed in 53 patients (30.6%). In patients without a
previous mitral procedure, the rate of repair was 82%
and 76% in the subgroup of patients with a degenerative
disease.gery c December 2014
FIGURE 1. Diagram of our favored operative setup.MV, Mitral valve;CT, computed tomography;US, ultrasonography;MIMVS, minimally invasive mitral
valve surgery; CPB, cardiopulmonary bypass; ITA, internal thoracic artery.
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The 30-day mortality rate was 4.1% (n ¼ 7). Causes of
death were low cardiac output syndrome in 3 patients, mul-
tiorgan failure in 1, neurologic complication in 1, and sepsis
in 1. Stroke was observed in 11 patients (6.3%), transient in
9 patients and permanent in 2. Although not significant, we
observed a trend suggesting a higher rate of stroke in pa-
tients who underwent the operation with femoral artery can-
nulation. Postoperative acute renal failure occurred in
11.5% (n ¼ 20). Hemodialysis was necessary in 4 of these
patients (2.3%). Pulmonary complications were observed
in 20 patients (11.5%). No perioperative myocardial infarc-
tion was observed. Reoperations for bleeding were neces-
sary in 11 patients (6.3%). Mean time of postoperative
mechanical ventilatory support was 14  18 hours. Mean
length of stay in the intensive care unit was 2.1  4.3
days and mean hospital stay was 10 5.9 days. Amorbidity
analysis for all patients is shown in Table 4. Early reopera-
tion (<30 days) was necessary in 1 patient because of valve
repair failure. The operation was reperformed through the
right minithoracotomy and the valve was rerepaired. Blood
transfusions were required in 68 patients (40.7%) at a mean
1.4  1.1 units/patient. Echocardiography at hospital
discharge revealed the absence or minimal residual mitral
regurgitation in all patients who underwent mitral valve
repair except 1 patient who had a moderate mitral regurgi-
tation. Independent risk predictors of 30-day mortality were
endocarditis (odds ratio [OR], 5.84; 95% confidence inter-
val [CI], 1.09-31.1; P ¼ .03) and peripheral arteriopathy
(OR, 6.26; 95% CI, 1.29-30.1; P ¼ .02).The Journal of Thoracic and CarFollow-up
Mean follow-up was 3.3 2.6 years and was 100% com-
plete. Late death occurred in 17 patients (1 sudden death, 11
cardiac-related deaths, and 5 non–cardiac-related deaths).
The mean New York Heart Association class at follow-up
was 1.5  0.6. There was 1 late reintervention at 1.1 year
for mitral prosthesis endocarditis. Survival at 1, 5 months,
and 10 years was 93.1%  1.9%, 87.5%  2.7%, and
79.7% 3.8%, respectively (Figure 2). Echocardiographic
follow-up of the 53 patients who underwent mitral repair re-
vealed moderate mitral regurgitation in 7 patients. All the
others had none or trivial mitral regurgitation.
In the multivariate Cox proportional hazards model, the
variables that emerged as independent predictors of long-
term mortality were age (hazard ratio [HR], 1.06; 95%
CI, 1.02-1.21; P ¼ .04) and endocarditis (HR, 3.31; 95%
CI, 0.98-11.1; P ¼ .03).
COMMENT
At our center, right minithoracotomy with ascending
aorta cannulation, femoral venous drainage, and transtho-
racic aortic clamping have become the approach of choice
for mitral valve operations since 2003,7 Early in our experi-
ence, we recognized the advantages of this technique for re-
operative procedures. With this access, the heart, great
vessels, and patent bypass grafts are far away from thework-
ing field and were not injured in any of our patients. Avoid-
ance of previously dissected tissue and less need for surgical
dissection can prevent the need for transfusion due to post-
operative hemorrhage and the need for reexploration duediovascular Surgery c Volume 148, Number 6 2765
TABLE 1. Preoperative characteristics
Number (N ¼ 173) %
Age, y  SD 61.3  12.4
Age 80 y 14 8.1
Female 80 46.7
Smoker 57 33.3
Extracardiac arteriopathy 33 19.3
Hypertension 100 58.4
Diabetes 27 15.7
COPD 20 11.6
Chronic renal failure 8 4.6
History of atrial fibrillation 89 52
Cerebrovascular disease 26 15.2
NYHA functional class III-IV 94 54.9
LVEF (%) 50  16
LVEF<35% 27 15.7
Predominant valve lesion
MV regurgitation 153 89.4
MV stenosis 20 10.6
TV regurgitation 47 26.1
Cause
Functional 16 9.3
Ischemic 24 14
Rheumatic 32 18.7
Endocarditis 16 9.3
Degenerative 53 30.9
Congenital 3 1.7
Prosthesis dysfunction 26 15.2
SD, Standard deviation; COPD, chronic obstructive pulmonary disease; NYHA, New
York Heart Association; LVEF, left ventricular ejection fraction;MV, mitral valve; TV,
tricuspid valve.
TABLE 3. Operative data
Number %
Femoral venous cannulation 171 100
Jugular vein cannulation 5 2.9
Femoral artery cannulation 118 68.3
Ascending aortic cannulation 55 31.7
Direct aortic clamping 58 33.5
Endoaortic balloon clamping 72 41.6
Hypothermic ventricular fibrillation 23 13.2
Beating heart 20 11.5
CPB time, min  SD 160  58
Crossclamp time, min  SD 82  49
Conversion to sternotomy 2 1.1
Procedures
Mitral valve repair 53 30.6
Annuloplasty 53 100
Leaflet procedure 32 65
Neochordae 9 18.3
Mitral valve replacement 114 65.8
Bioprosthesis 40 35
Mechanical prosthesis 73 65
Paraprosthetic leak repair 6 3.4
Tricuspid valve repair 33 19.1
AF ablation 5 2.8
ASD/PFO closure 5 2.8
CPB, Cardiopulmonary bypass; SD, standard deviation; AF, atrial fibrillation; ASD,
atrial septal defect; PFO, patent foramen ovale.
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40.7% of the patients and the transfusion was required at a
mean of 1.4  1.1 units/patient. Concerns about MIMVS
are related to suboptimal exposure and prolonged
cardiopulmonary bypass time.14 In our experience, right
minithoracotomy allows straight access to the mitral valve
without the need for extensive cardiac mobilization as in
standard redo procedures. This is supported by the fact
that in our series, no patient required conversion to sternot-
omy because of difficult mitral valve exposure or major
vascular injury. The minimally invasive approach guaran-
tees a safe and excellent view of all the valve apparatus, al-
lowing all types of repair techniques such as neochordal
placement and anterior leaflet repair. In our series, mitral
valve repair was performed in 82% of patients without pre-
vious mitral valve surgery and in 25% of patients with aTABLE 2. Previous operation
Type Number %
Mitral procedure 120 70.1
CABG 49 28.6
AVR 32 18.7
Aorta procedure 3 1.7
Tricuspid procedure 11 6.4
CABG, Coronary artery bypass grafting; AVR, aortic valve replacement.
2766 The Journal of Thoracic and Cardiovascular Surprevious mitral valve repair. The right chest approach did
not impede the replacement of a mitral prosthesis or repair
of a paravalvular leak. In our series, we have also applied
the technique to patients with active endocarditis. However,
in this subset of patients, it is extremely important to confirm
preoperatively the absence of any trigone or aortic valve
involvement. With regard to cardiopulmonary bypass time,
we found that our operative results compare favorably
with data reported in other series onmitral valve reoperation
performed through a similar approach as well as through
resternotomy,8-13,15,16 These results are encouraging
considering that adjunctive procedures were associated
with mitral valve surgery in about 25% of our patients.
Reoperative MIMVS has been shown to have similar
mortality andmorbidity comparedwith standard sternotomy
procedures.2,8,15 However, some studies have reported
a greater incidence of neurologic complications with
a minimally invasive approach.17-20 Svensson and
colleagues17 showed that right thoracotomy carries an unac-
ceptable risk of stroke compared with resternotomy during
reoperative mitral valve surgery (right thoracotomy 7.5%
vs 2.7% resternotomy; P ¼ .006). The investigators identi-
fied the use of retrograde arterial cannulation, ventricular
fibrillatory arrest, and incomplete deairing as risk factors
for the increased risk of stroke. In response to this study,
in 2010 Crooke and colleagues4 analyzed a series of 905 pa-
tients who underwent reoperative mitral valve proceduresgery c December 2014
TABLE 4. Postoperative morbidity
Complication Number %
30-d mortality 7 4.1
Stroke 11 6.3
Transient 9 81.8
Permanent 2 18.2
Delirium 20 11.5
Postoperative AMI 0 0
Pulmonary complications 20 11.5
Renal failure 20 11.5
New-onset dialysis 4 2.3
Reoperation for bleeding 11 6.3
Atrioventricular block 6 3.4
Postoperative AF 54 31.2
AMI, Acute myocardial infarction; AF, atrial fibrillation.
Murzi et al Acquired Cardiovascular Diseasethrough a median sternotomy (612; 67.6%), right anterior
thoracotomy (242; 26.7%), and left posterior thoracotomy
in (51; 5.6%). In their analysis, the incidence of stroke
was linked to retrograde arterial perfusion and not to the
location of the incision, suggesting a more liberal use of an-
tegrade perfusion.Recently,we carried out a similar analysis
on 1280 nonreoperativeMIMVS and our results confirm the
negative impact of retrograde arterial cannulation on
neurologic outcome.21 Because of concerns regarding the
negative impact of retrograde perfusion on neurologic
outcome, our strategy has progressively evolved from
femoral artery cannulation to direct ascending aorta cannu-
lation. In practice, we avoid retrograde perfusion whenever
possible, restricting femoral artery cannulation only to cir-
cumstances where direct ascending aorta cannulation isFIGURE 2. Kaplan-M
The Journal of Thoracic and Carprohibitive, such as patent coronary bypass or hostile medi-
astinum. In addition, as part of our stroke prevention proto-
col, we always use CO2 insufflation in the surgical field to
reduce the amount of intracardiac air, andwe leave the trans-
mitral and aortic root vent in place until the heart is fully
beating and no more bubbles are seen on transesophageal
echocardiography. Since adopting this procedure, we have
noted a significant reduction in stroke rate, from 8.3% in
the first 123 patients to 2% in the last 50 patients.
Reoperative MIMVS in the presence of patent left inter-
nal thoracic grafts represents a particular challenge because
these grafts cannot be isolated and clamped during cardio-
plegia delivery. In this subset of patients, we have routinely
used systemic cooling and ventricular fibrillation. The
absence of perioperative myocardial infarction and the
low incidence of low cardiac output syndrome are evidence
of the success of this strategy. Our results reconfirm the
safety and efficacy of not clamping a patent left internal
thoracic artery graft and mitigate its presence by the strat-
egy of additional core cooling.22 Alternatively, in this sub-
set of patients, systemic cooling with cardiac arrest by
administration of cold antegrade crystalloid cardioplegia
or beating heart surgery may be safely performed.23
In our series, the30-daymortality (4.1%) compared favor-
ably with other studies in which mitral valve reoperations
were performed either through a right thoracotomy8-13 or
through a standard sternotomy.15,16 Although it is difficult
to compare results from different series because of
differences in patient populations, we can conclude that
our observed mortality rate of 4.1% confirms that MIMVSeier survival curve.
diovascular Surgery c Volume 148, Number 6 2767
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mitral valve reoperation. Of particular interest is the fact
that mortality in our study was significantly lower than
the expected mortality predicted by the euroSCORE
(observed/expected ratio, 0.12). Although it is widely
accepted that the euroSCORE tends to overestimate
the operative mortality of patients undergoing valvular
surgery,24 we believe that the practical and potential benefits
of the minithoracotomy approach, and in particular reduced
surgical dissection, good exposure, good myocardial protec-
tion, and low need for blood transfusion, might have contrib-
uted to these results.
Additional procedures, such as tricuspid valve surgery or
atrial fibrillation ablation, can be safely performed through
a right minithoracotomy. At the beginning of our experi-
ence, right atrial procedures were performed with bicaval
cannulation and tapes around the venae cavae. However,
in redo procedures, placement of caval snares may be
particularly challenging through a very small incision and
may expose the patient to the risks of caval bleeding and
laceration. Therefore, since April 2007, we have shifted to
a double-stage single femoral venous cannula that has 2
distal perforated sections separated by a nonperforated
segment of 15 cm in length, ideated to drain the inferior
and superior venae cavae simultaneously. The use of this
cannula offers many advantages over bicaval cannulation.
First, it avoids complications related to the insertion of a
right internal jugular vein cannula, such as bleeding, hema-
toma, inadvertent carotid lesions, and pneumothorax. Sec-
ond, this cannula achieves a satisfactory bloodless
working field without occluding the venae cavae.6
Limitations of the Study
There are several limitations of this study. This is a retro-
spective study at a single center and thus it is inevitably
biased in patient selection and the technique used. In addi-
tion, our report includes our initial experience. The fact that
we cannot compare our series with a cohort of patients un-
dergoing resternotomy is another important limitation.
CONCLUSIONS
Our study suggests that reoperative mitral valve surgery
can be safely performed through a right minithoracotomy
with low morbidity and mortality and with acceptable
midterm results. The avoidance of extensive surgical
dissection, good exposure of the valve, low requirement
for blood transfusion, and short hospital stay are the main
advantages of this technique.
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